News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NeurOp Corporation Announces Extension to Drug Discovery Collaboration with Bristol-Myers Squibb Company (BMY)



12/14/2011 6:33:21 AM

ATLANTA--(BUSINESS WIRE)--NeurOp, Inc. today announced that Bristol-Myers Squibb (NYSE: BMY) has agreed to fund an additional year of research for NeurOp’s proprietary small molecules for the treatment of major depression and neuropathic pain.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES